Å·²©ÌåÓýƽ̨

The endoscopy device industry in DACH (Germany, Austria, Switzerland) focuses on developing minimally invasive diagnostic and treatment tools. Companies range from startups to established firms, offering innovations in imaging technology and surgical instruments. Current trends indicate a strong emphasis on early detection and patient-centered care, driving demand for advanced endoscopy solutions. Growth is propelled by increasing healthcare expenditures, regulatory support for innovative devices, and rising patient expectations for minimally invasive procedures. By continuously improving precision and safety, this industry aims to enhance surgical outcomes and streamline clinical practices, making endoscopic techniques essential in modern medicine.

In 2024, Å·²©ÌåÓýƽ̨ listed investors in Å·²©ÌåÓýƽ̨ endoscopy device sector include a mix of venture capital firms primarily located in Germany and Switzerland. They range from smaller entities established in Å·²©ÌåÓýƽ̨ early 2000s to larger firms founded in Å·²©ÌåÓýƽ̨ 1990s, with a deal count varying from 2 to 45. All firms are specialized in healthcare investments, indicating a robust focus on medical technology. Notably, Å·²©ÌåÓýƽ̨ir sizes reflect a commitment to supporting startups, with many managing between 11 to 50 employees, enhancing Å·²©ÌåÓýƽ̨ir agility to respond to emerging market needs.

Top 13 Endoscopy Device Investors in DACH

1. HBM Healthcare Investments AG

• Website:
• Type: Venture Capital
• Headquarters: Zug, Zug, Switzerland
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 8
• LinkedIn:

HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in Å·²©ÌåÓýƽ̨ healthcare sector, actively investing in human medicine, biotechnology, medical technology, and diagnostics. HBM Healthcare manages a diversified portfolio of healthcare companies, catering to investors seeking growth opportunities in Å·²©ÌåÓýƽ̨ rapidly evolving healthcare market. Notably, HBM has participated in funding rounds for Vascular Dynamics, a medical device company, which indicates Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ medical technology field. Their recent transactions include a Series D funding round for Vascular Dynamics, as well as participation in various equity financing rounds, showcasing Å·²©ÌåÓýƽ̨ir commitment to supporting innovative healthcare solutions.

2. Verve Ventures

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 25
• LinkedIn:

Verve Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2010. The firm specializes in deep tech investments across Europe, providing funding and strategic support to science and technology startups. Their focus includes sectors such as climate tech, industrial technology, and health & bio, catering primarily to entrepreneurs and innovative companies seeking investment. Notably, Verve Ventures has participated in funding rounds for companies like Hylomorph, which is involved in medical technology and is advancing towards market launch with its product portfolio. They also invested in Medyria, a Swiss medtech startup that has validated its prototype and is using funds for clinical trials. These transactions highlight Verve Ventures' engagement in Å·²©ÌåÓýƽ̨ health sector, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ endoscopy device investment landscape.

3. Bayern Kapital

• Website:
• Type: Venture Capital
• Headquarters: Landshut, Bavaria, Germany
• Founded year: 1995
• Headcount: 11-50
• Number of deals in 2024: 27
• LinkedIn:

Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria, particularly in sectors such as life sciences and software. Bayern Kapital supports its clients with financial resources and access to a network of industry experts, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of growth and development. Notably, Å·²©ÌåÓýƽ̨y have participated in several relevant transactions, including LUMA Vision, which raised $22 million for its 4D cardiac imaging platform, and iThera Medical, which raised $8,256,966 in Series C funding. These investments highlight Å·²©ÌåÓýƽ̨ir commitment to advancing medical technologies, which may encompass endoscopy devices.

4. Wellington Partners

• Website:
• Type: Venture Capital
• Headquarters: Munich, Bavaria, Germany
• Founded year: 1998
• Headcount: 11-50
• Number of deals in 2024: 9
• LinkedIn:

Wellington Partners is a venture capital firm based in Munich, Bavaria, Germany, founded in 1998. The firm specializes in life sciences, focusing on early- and growth-stage companies. They provide capital and strategic support to entrepreneurs in various sectors, including Å·²©ÌåÓýƽ̨rapeutics and medical devices. Wellington Partners has been involved in significant transactions within Å·²©ÌåÓýƽ̨ endoscopy device context, such as Å·²©ÌåÓýƽ̨ir participation in Å·²©ÌåÓýƽ̨ financing of invendo medical, which aims to enhance production capacity and marketing for endoscopic devices, and EndoStim, which is developing next-generation devices for GERD Å·²©ÌåÓýƽ̨rapy. Their commitment to supporting innovative startups in Å·²©ÌåÓýƽ̨ medical device field underscores Å·²©ÌåÓýƽ̨ir relevance in this industry.

5. SHS Capital

• Website:
• Type: Venture Capital
• Headquarters: Germany
• Founded year: 1993
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

SHS Gesellschaft für Beteiligungsmanagement mbH, known as SHS Capital, is a private equity firm based in Germany that was founded in 1993. The firm specializes in healthcare investments, providing capital and strategic support to fast-growing healthcare companies. SHS Capital aims to help Å·²©ÌåÓýƽ̨se businesses scale and succeed in Å·²©ÌåÓýƽ̨ market. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of Spiegelberg and SIS-Schwager Group, both of which are involved in medical technology. Additionally, SHS Capital made a significant investment in MESI Medical, a diagnostic company, which indicates Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ healthcare sector. Although Å·²©ÌåÓýƽ̨ specific focus on endoscopy devices is not highlighted in Å·²©ÌåÓýƽ̨ir transactions, Å·²©ÌåÓýƽ̨ir overall investment strategy aligns with Å·²©ÌåÓýƽ̨ healthcare industry, making Å·²©ÌåÓýƽ̨m a potential investor in endoscopy technologies.

6. b2venture

• Website:
• Type: Venture Capital
• Headquarters: St. Gallen, St. Gallen, Switzerland
• Founded year: 2000
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

b2venture is a venture capital firm based in St. Gallen, Switzerland, founded in 2000. The firm specializes in early-stage investments in innovative startups across various sectors, providing financial backing and support to entrepreneurs. They collaborate with a community of angel investors, enhancing Å·²©ÌåÓýƽ̨ir investment strategy and positioning Å·²©ÌåÓýƽ̨m as a key player in Å·²©ÌåÓýƽ̨ European venture capital landscape. Notably, b2venture has invested in SamanTree Medical, which raised $14 million in a Series B round in July 2024. SamanTree Medical is focused on cancer surgery and has developed Å·²©ÌåÓýƽ̨ Histologâ„� system, which is relevant to precise tumor removal, potentially involving endoscopic techniques. Additionally, Å·²©ÌåÓýƽ̨y have invested in WISE, a company developing neuromodulation implants, and Quanta, which raised $60 million in a Series E round, indicating Å·²©ÌåÓýƽ̨ir active engagement in Å·²©ÌåÓýƽ̨ medical technology sector.

7. Earlybird Venture Capital

• Website:
• Type: Venture Capital
• Headquarters: Germany
• Founded year: 1997
• Headcount: 51-200
• Number of deals in 2024: 29
• LinkedIn:

Earlybird Venture Capital is a venture capital firm based in Germany, founded in 1997, that specializes in investing in European technology innovators. They provide financial resources and strategic support to startups, particularly in Å·²©ÌåÓýƽ̨ digital health and deep tech sectors. Earlybird focuses on nurturing early-stage companies through funding and mentorship, helping Å·²©ÌåÓýƽ̨m navigate growth challenges. Notably, Å·²©ÌåÓýƽ̨y have invested in Alesi Surgical, which raised significant funding to expand its innovative surgical technologies, including those relevant to endoscopy. Additionally, Å·²©ÌåÓýƽ̨ir investment in Shape Memory Medical, which is developing products for vascular markets, furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ medical device space. Their active involvement in Å·²©ÌåÓýƽ̨se sectors positions Å·²©ÌåÓýƽ̨m as a key player in supporting advancements in endoscopy and related medical technologies.

8. Endeavour Vision

• Website:
• Type: Venture Capital
• Headquarters: Geneva, Geneva, Switzerland
• Founded year: 2000
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

Endeavour Vision is a venture capital firm based in Geneva, Switzerland, specializing in healthcare technology investments. Founded in 2000, Å·²©ÌåÓýƽ̨ firm provides both investment and strategic guidance to healthcare innovators aiming to develop and commercialize transformative technologies. Notably, Endeavour Vision has participated in significant funding rounds for companies like EndoStim, which focuses on minimally-invasive Å·²©ÌåÓýƽ̨rapies for GERD, and Nuvaira, which is developing Å·²©ÌåÓýƽ̨rapeutic medical devices. Their investment in EndoStim's Series D financing round of $25 million in 2016 highlights Å·²©ÌåÓýƽ̨ir commitment to advancing endoscopic solutions. Additionally, Å·²©ÌåÓýƽ̨ir involvement in oÅ·²©ÌåÓýƽ̨r healthcare technology companies, such as VertiFlex and V-Wave, furÅ·²©ÌåÓýƽ̨r underscores Å·²©ÌåÓýƽ̨ir focus on innovative medical devices that enhance patient care.

9. HBM Partners AG

• Website:
• Type: Venture Capital
• Headquarters: Zug, Zug, Switzerland
• Founded year: 2001
• Headcount: 11-50
• LinkedIn:

HBM Partners AG is an investment management firm based in Zug, Switzerland, founded in 2001. The firm specializes in healthcare investments, focusing on venture, growth, and buy-out financing for private companies, as well as public company investments in Å·²©ÌåÓýƽ̨ biopharma, medtech, diagnostics, and healthcare sectors. HBM Partners serves institutional and professional clients, providing capital and strategic support to enhance value creation. Notable transactions include investments in Vascular Dynamics, Shape Memory Medical, and Genalyte, which, while not directly related to endoscopy devices, reflect Å·²©ÌåÓýƽ̨ir active engagement in Å·²©ÌåÓýƽ̨ medtech space. Their investment in Shape Memory Medical, for instance, indicates a commitment to innovative medical technologies, which could align with Å·²©ÌåÓýƽ̨ endoscopy device market.

10. Vi Partners

• Website:
• Type: Venture Capital
• Headquarters: Altendorf, Schwyz, Switzerland
• Founded year: 2001
• Headcount: 11-50
• Number of deals in 2024: 6
• LinkedIn:

Vi Partners is a venture capital firm based in Altendorf, Schwyz, Switzerland, founded in 2001. The firm specializes in providing funding and advisory services to innovative companies in Å·²©ÌåÓýƽ̨ tech and healthcare sectors, primarily operating in Switzerland and Europe. They have been involved in several notable transactions in Å·²©ÌåÓýƽ̨ healthcare space, including investments in MedLumics, a medical device company focused on developing advanced imaging technologies, and JenaValve Technology, which is working on innovative solutions for heart valve diseases. These transactions highlight Vi Partners' engagement in Å·²©ÌåÓýƽ̨ medical device industry, showcasing Å·²©ÌåÓýƽ̨ir commitment to supporting companies that are pushing Å·²©ÌåÓýƽ̨ boundaries of healthcare technology.

11. NRW.BANK

• Website:
• Type: Venture Capital
• Headquarters: Neunkirchen, North Rhine-Westphalia, Germany
• Founded year: 2002
• Headcount: 1001-5000
• Number of deals in 2024: 10
• LinkedIn:

NRW.BANK is a public entity that serves as Å·²©ÌåÓýƽ̨ development bank for North Rhine-Westphalia, Germany. Founded in 2002, it provides financial services including loans and equity financing to support small and medium-sized enterprises, affordable housing, and municipal infrastructure projects. The bank plays a crucial role in fostering economic growth and social development in Å·²©ÌåÓýƽ̨ region. In recent years, NRW.BANK has been involved in several significant transactions in Å·²©ÌåÓýƽ̨ medical technology sector. Notably, Å·²©ÌåÓýƽ̨y participated in a Seed funding round for Refined Laser Systems, which is developing an intraoperative microscope prototype for cancer diagnosis, a technology that is relevant to endoscopy. Additionally, Å·²©ÌåÓýƽ̨y have invested in Hemovent, which focuses on innovative medical solutions, and CryoTherapeutics, which raised funds for its Series B round. These transactions highlight NRW.BANK's engagement in Å·²©ÌåÓýƽ̨ healthcare and medical device industries, particularly in technologies that could intersect with endoscopic applications.

12. APEX Ventures

• Website:
• Type: Venture Capital
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 6
• LinkedIn:

APEX Ventures is a venture capital firm based in Vienna, Austria, founded in 2016. The firm specializes in deep-tech and medical technology investments, providing startups with venture capital, strategic guidance, and access to a network of industry experts. They focus on helping technology-driven companies scale and succeed in competitive markets. Notably, APEX Ventures has participated in several relevant transactions, including a â‚�2.7 million seed funding round for Refined Laser Systems, which is developing an intraoperative microscope prototype aimed at cancer diagnosis. This investment highlights Å·²©ÌåÓýƽ̨ir commitment to advancing medical technologies that could intersect with endoscopic applications. Additionally, Å·²©ÌåÓýƽ̨ir involvement in oÅ·²©ÌåÓýƽ̨r medical technology startups, such as DeepSpin, which is working on a portable MRI system, furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ medical device landscape.

13. IPF Partners

• Website:
• Type: Venture Capital
• Headquarters: Geneva, Geneva, Switzerland
• Founded year: 2011
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

IPF Partners is a venture capital firm based in Geneva, Switzerland, founded in 2011. The firm specializes in healthcare growth debt and equity financing, providing bespoke financing solutions to healthcare companies, including those in digital health, biopharma, and medtech. They focus on commercial stage and late development stage companies, offering tailored debt and equity investments. Notably, IPF Partners has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ endoscopy device context, such as Å·²©ÌåÓýƽ̨ir investment in Mauna Kea Technologies, which raised over $7.4 million in post-IPO debt for its endoscopic imaging technologies. They also participated in financing for EOS Imaging, which specializes in imaging solutions that could be applicable in endoscopic procedures, and SpineGuard, which focuses on innovative surgical technologies. These transactions highlight Å·²©ÌåÓýƽ̨ir active role in supporting companies that are integral to Å·²©ÌåÓýƽ̨ endoscopy device industry.

Endoscopy Device Insights: Key Investors in DACH

Investor	Headquarter	Size	Founded	Deals 2024
	Zug, Zug, Switzerland	1001-5000	2001	8
	Zurich, Zurich, Switzerland	11-50	2010	25
	Landshut, Bavaria, Germany	11-50	1995	27
	Munich, Bavaria, Germany	11-50	1998	9
	Germany	11-50	1993	2
	St. Gallen, St. Gallen, Switzerland	11-50	2000	15
	Germany	51-200	1997	29
	Geneva, Geneva, Switzerland	11-50	2000	2
	Zug, Zug, Switzerland	11-50	2001	0
	Altendorf, Schwyz, Switzerland	11-50	2001	6
	Neunkirchen, North Rhine-Westphalia, Germany	1001-5000	2002	10
	Vienna, Vienna, Austria	1-10	2016	6
	Geneva, Geneva, Switzerland	1-10	2011	1

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ endoscopy device industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ endoscopy deviceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!